Chuan-Ben Chen (Chuanben Chen)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Top Venues

BioMed research international

Computational and mathematical methods in medicine

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Jianming Ding, Liqian, Yuhao Lin, Xiaobing Zheng, Chaoxiong Huang, Jiabiao Hong, Chuan-Ben Chen, Zhaodong Fei
Baseline SUVmax is correlated with tumor hypoxia and patient outcomes in nasopharyngeal carcinoma. Scientific reports 14 (1) (2024)
Jianming Ding, Liqian, Yuhao Lin, Xiaobing Zheng, Chaoxiong Huang, Jiabiao Hong, Chuan-Ben Chen, Zhaodong Fei
Baseline SUVmax is correlated with tumor hypoxia and patient outcomes in nasopharyngeal carcinoma. Scientific reports 14 (1) (2024)
Ye Feng, Ting Xu, Yiying Xu, Ziyi Wu, Huiling Hong, Ying-Ying Huang, Xiyi Liao, Xiaobin Fu, Jiawei Chen, Xiufang Qiu, Jianming Ding, Chaoxiong Huang, Li Li, Chuan-Ben Chen, Zhaodong Fei
Do all patients at the initial stage of nasopharyngeal carcinoma need bone metastasis screening? A retrospective study. Head & neck (2023)
Lizhu Chen, Yaoming Wen, Jiani Xiong, Yu Chen, Chuan-Ben Chen
An Immunogenic Cell Death-Related Gene Signature Reflects Immune Landscape and Predicts Prognosis in Melanoma Independently of BRAF V600E Status. BioMed research international 2023 (2023)
Lizhu Chen, Yaoming Wen, Jiani Xiong, Yu Chen, Chuan-Ben Chen
An Immunogenic Cell Death-Related Gene Signature Reflects Immune Landscape and Predicts Prognosis in Melanoma Independently of BRAF V600E Status. BioMed research international 2023 (2023)
Lizhu Chen, Yaoming Wen, Jiani Xiong, Yu Chen, Chuan-Ben Chen
An Immunogenic Cell Death-Related Gene Signature Reflects Immune Landscape and Predicts Prognosis in Melanoma Independently of BRAF V600E Status. BioMed research international 2023 (2023)
Xiang Lin, Bingyi Wang, Fei Zheng, Zhaodong Fei, Chuan-Ben Chen
Prognostic Relevance of Change in Body Mass Index in Patients With Nasopharyngeal Carcinoma Undergoing Volumetric Modulated Arc Therapy: A Retrospective Study. Cancer control : journal of the Moffitt Cancer Center 29 (2022)
Ye Feng, Yiying Xu, Ting Xu, Huiling Hong, Jiawei Chen, Xiufang Qiu, Jianming Ding, Chaoxiong Huang, Li Li, Jing Liu, Zhaodong Fei, Chuan-Ben Chen
Recommendation for imaging follow-up strategy based on time-specific disease failure for nasopharyngeal carcinoma. Head & neck 45 (3) (2022)
Ye Feng, Yiying Xu, Ting Xu, Huiling Hong, Jiawei Chen, Xiufang Qiu, Jianming Ding, Chaoxiong Huang, Li Li, Jing Liu, Zhaodong Fei, Chuan-Ben Chen
Recommendation for imaging follow-up strategy based on time-specific disease failure for nasopharyngeal carcinoma. Head & neck (2022)
Lizhu Chen, Jie Lin, Bin Lan, Jiani Xiong, Yaoming Wen, Yu Chen, Chuan-Ben Chen
FAM3D as a Prognostic Indicator of Head and Neck Squamous Cell Carcinoma Is Associated with Immune Infiltration. Computational and mathematical methods in medicine 2022 (2022)
Lizhu Chen, Jie Lin, Bin Lan, Jiani Xiong, Yaoming Wen, Yu Chen, Chuan-Ben Chen
FAM3D as a Prognostic Indicator of Head and Neck Squamous Cell Carcinoma Is Associated with Immune Infiltration. Computational and mathematical methods in medicine 2022 (2022)
Ye Feng, Yiying Xu, Ting Xu, Huiling Hong, Jiawei Chen, Xiufang Qiu, Jianming Ding, Chaoxiong Huang, Li Li, Jing Liu, Zhaodong Fei, Chuan-Ben Chen
Recommendation for imaging follow-up strategy based on time-specific disease failure for nasopharyngeal carcinoma. Head & neck 45 (3) (2022)
Ye Feng, Yiying Xu, Ting Xu, Huiling Hong, Jiawei Chen, Xiufang Qiu, Jianming Ding, Chaoxiong Huang, Li Li, Jing Liu, Zhaodong Fei, Chuan-Ben Chen
Recommendation for imaging follow-up strategy based on time-specific disease failure for nasopharyngeal carcinoma. Head & neck 45 (3) (2022)
Zhaodong Fei, Ting Xu, Xiufang Qiu, Mengying Li, Taojun Chen, Li Li, Chaoxiong Huang, Chuan-Ben Chen
Significance of boost dose for T4 nasopharyngeal carcinoma with residual primary lesion after intensity-modulated radiotherapy. Journal of cancer research and clinical oncology 147 (7) (2021)
Yu Chen, Yi Li, Jiani Xiong, Bin Lan, Xuefeng Wang, Jun Liu, Jing Lin, Zhaodong Fei, Xiaobin Zheng, Chuan-Ben Chen
Role of PRKDC in cancer initiation, progression, and treatment. Cancer cell international 21 (1) (2021)
Yu Chen, Yi Li, Yanfang Guan, Yingying Huang, Jing Lin, Lizhu Chen, Jin Li, Gang Chen, Leong Kin Pan, Xuefeng Xia, Ning Xu, Lianpeng Chang, Zengqing Guo, Jianji Pan, Xin Yi, Chuan-Ben Chen
Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors. Molecular oncology 14 (9) (2020)